Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens

NCT00646555 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00646555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00646555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
November 20, 2003
Completion date
April 10, 2012
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms